What changed
$NVDA — AVOID 📊 | 6 MONTHS THESIS
🎯 FQ1 FY2027 (ends Apr) | reported May 20 | Rev $81.6B | EPS $1.87 vs $1.77 🟢 | Margin 69.0%
💡 Consensus expects continued hypergrowth and margin expansion after the EPS beat, but the market is pricing in low double-digit earnings growth indefinitely, ignoring potential mean reversion in semiconductor cycles and rising competition; my variant view is that growth will decelerate and the multiple will compress toward historical norms.
📉 Reward/risk: 2.24:1
🏢 Business Quality: 9/10
📊 Valuation: rich — current P/E 31.5x vs historical range 2.6x–28.1x (113th percentile) and peer range 7.3x–48.1x; base case 18.2x P/E yields $231.67 (17.7%...
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/NVDA0625